You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Gilead’s COVID-19 drug remdesivir bags US approval

Gilead’s antiviral treatment remdesivir has been approved by the US Food and Drug Administration (FDA) for the treatment of COVID-19 patients requiring hospitalisation.